A Study of "Drug Entry Lags" Between Japan and the US: Compering the Timing of a New Drug Entry, Generic Entry and Market Exclusivity Periods
(PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 2016)
Evolution of Intellectual Property Protection for Pharmaceuticals in Japan and its future outlook
(2013 Pharmaceutical Intellectual Property Forum 2013)